Woods Keith
SEC-identified person · CIK 1996804 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Neurogene Inc. NLTX | Director | filed 2026–2026 |
| Tscan Therapeutics, Inc. TCRX | Director | filed 2023–2026 |
| Scholar Rock Holding Corp SRRK | Chief Operating Officer | filed 2025–2026 |
| X4 Pharmaceuticals, Inc XFOR | Director | filed 2023–2025 |
| Rocket Pharmaceuticals, INC. RCKT | Director | filed 2023–2024 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.